ArticleCancers2020

Drug Vulnerabilities and Disease Prognosis Linked to the Stem Cell-Like Gene Expression Program Triggered by the RHO GTPase Activator VAV2 in Hyperplastic Keratinocytes and Head and Neck Cancer.

Luis Francisco Lorenzo-Martín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.